Galletta Christopher - Insider Non-Derivative Transactions at Trevi Therapeutics, Inc. (TRVI) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 2, 2025, Galletta Christopher's relationship to Trevi Therapeutics, Inc. (TRVI) is Officer (See Remarks), and currently has 26,095 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other TRVI insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Galletta Christopher - Insider Non-Derivative Transactions of TRVI Common Stock

Galletta Christopher - Insider Non-Derivative Transactions at TRVI

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 3, 2025	M -- (Common Stock)	4225	0.51	26095
Dec 14, 2024	M -- (Common Stock)	15000	0.51	19935